Literature DB >> 10665955

Complex chromosome aberrations in peripheral blood lymphocytes as a potential biomarker of exposure to high-LET alpha-particles.

R M Anderson1, S J Marsden, E G Wright, M A Kadhim, D T Goodhead, C S Griffin.   

Abstract

PURPOSE: To determine the induction and transmission, to second and third division cells, of complex chromosome aberrations in peripheral blood lymphocytes after exposure to high-LET alpha-particles in vitro.
MATERIALS AND METHODS: Separated peripheral blood lymphocytes collected from four healthy donors were irradiated in vitro with either high-LET alpha-particles (121 keV/microm; 0.5 Gy) or low-LET X-rays (250kV constant potential; 3 Gy). Cells were harvested in first, second and third division post-irradiation and chromosome aberrations observed at each cell division were analysed by combining the techniques of FISH and DAPI/Hoechst 33258 harlequin staining. Whole chromosome probes were used for chromosomes 1, 2 and 5, together with a pan-centromeric probe and the resulting chromosome 'painting' patterns were classified according to the Savage and Simpson (S & S) scheme (Savage and Simpson 1994a, Savage and Tucker 1996).
RESULTS: A greater proportion of complex chromosome aberrations was observed, defined as involving three or more breaks in two or more chromosomes, relative to total exchanges, after exposure to 0.5 Gy alpha-particles (mean 1 track/cell) than after the high reference dose of 3 Gy X-rays (49-56% and 20-22%, respectively). Qualitatively, alpha-particles induced chromosome aberrations of far greater complexity than those observed after X-rays. This was reflected by both the rapid reduction in the percentage of damaged cells between first and second division indicative of cell death, and the spectrum of aberration types observed in second and third division cells post-irradiation. Regardless of this complexity, 15% of the complexes induced by alpha-particles at first division were potentially transmissible and by third division, transmissible-type complexes, specifically insertions, represented the predominant complex type (65%).
CONCLUSION: Transmissible-type complexes were observed, specifically insertions, in both second and third division cells after exposure to high-LET alpha-particles (0.5 Gy) in vitro. The authors predict these cells to be stable and to be capable of persisting through many cell generations. Considering that the induction of complex chromosome aberrations by low-LET radiation is strongly dependent on dose, so that they are expected to be undetectable at environmental exposures, insertions are much more likely to be a characteristic feature of high-LET radiation at all doses. From this the usefulness of insertions as biomarkers of past exposure to environmentally relevant doses of high-LET alpha-particles is supported.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10665955     DOI: 10.1080/095530000138989

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  21 in total

1.  M-FISH analysis shows that complex chromosome aberrations induced by alpha -particle tracks are cumulative products of localized rearrangements.

Authors:  Rhona M Anderson; David L Stevens; Dudley T Goodhead
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-30       Impact factor: 11.205

2.  Influence of mitotic delay on the results of biological dosimetry for high doses of ionizing radiation.

Authors:  A Heimers; H J Brede; U Giesen; W Hoffmann
Journal:  Radiat Environ Biophys       Date:  2005-11-05       Impact factor: 1.925

3.  Chromosome aberration measurements in mitotic and G2-PCC lymphocytes at the standard sampling time of 48 h underestimate the effectiveness of high-LET particles.

Authors:  Ryonfa Lee; Elena Nasonova; Carola Hartel; Marco Durante; Sylvia Ritter
Journal:  Radiat Environ Biophys       Date:  2011-04-11       Impact factor: 1.925

4.  Genomic instability after targeted irradiation of human lymphocytes: evidence for inter-individual differences under bystander conditions.

Authors:  Munira A Kadhim; Ryonfa Lee; Stephen R Moore; Denise A Macdonald; Kim L Chapman; Gaurang Patel; Kevin M Prise
Journal:  Mutat Res       Date:  2010-03-27       Impact factor: 2.433

5.  Chromosome aberrations in workers with exposure to α-particle radiation from internal deposits of plutonium: expectations from in vitro studies and comparisons with workers with predominantly external γ-radiation exposure.

Authors:  Gillian B Curwen; Natalia V Sotnik; Kevin K Cadwell; Tamara V Azizova; Mark A Hill; E Janet Tawn
Journal:  Radiat Environ Biophys       Date:  2015-02-04       Impact factor: 1.925

6.  Directional genomic hybridization: inversions as a potential biodosimeter for retrospective radiation exposure.

Authors:  F Andrew Ray; Erin Robinson; Miles McKenna; Megumi Hada; Kerry George; Francis Cucinotta; Edwin H Goodwin; Joel S Bedford; Susan M Bailey; Michael N Cornforth
Journal:  Radiat Environ Biophys       Date:  2014-01-30       Impact factor: 1.925

7.  mFISH analysis of chromosome aberrations in workers occupationally exposed to mixed radiation.

Authors:  Natalia V Sotnik; Sergey V Osovets; Harry Scherthan; Tamara V Azizova
Journal:  Radiat Environ Biophys       Date:  2014-04-09       Impact factor: 1.925

Review 8.  Crosstalk between telomere maintenance and radiation effects: A key player in the process of radiation-induced carcinogenesis.

Authors:  Grace Shim; Michelle Ricoul; William M Hempel; Edouard I Azzam; Laure Sabatier
Journal:  Mutat Res Rev Mutat Res       Date:  2014-01-31       Impact factor: 5.657

9.  The LET dependence of unrepaired chromosome damage in human cells: a break too far?

Authors:  Bradford D Loucas; Michael N Cornforth
Journal:  Radiat Res       Date:  2013-04       Impact factor: 2.841

10.  Mutagenesis and repair by low doses of alpha radiation in mammalian cells.

Authors:  Theodore T Puck; Robert Johnson; Patricia Webb; Helen Cui; Joseph G Valdez; Harry Crissman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.